Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07062172 · ClinicalTrials.gov registry record · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
A NA study of Lung Cancer and Driver Mutation, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 1,753
- Enrollment target
- 1
- Study location
NCT07062172: Recruiting NA study of Lung Cancer and Driver Mutation, sponsored by University of California, Irvine.
NCT07062172 is a NA study of Lung Cancer and Driver Mutation that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 1,753 participants, above the 932-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07062172, a NA study of Lung Cancer and Driver Mutation, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,753 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.
Primary Outcome
Determine the number of lung cancers found in low dose CT scans of first degree relatives of lung cancer patients with known driver mutations.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Low Dose CT Scan
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,753 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07062172 shows while recruiting
NCT07062172 is an interventional study that assigns participants to a tested intervention. Its 1,753 participants enrollment target places it among the larger protocols in the corpus, above the 932-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% higher).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Low Dose CT Scan is the first listed.
NCT07062172 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07062172 about?
NCT07062172 is a clinical study titled "Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer". This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and...
What is the current status of trial NCT07062172?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,753 participants. The study started on 2025-05-08. Estimated completion is 2028-12-31.
What conditions does trial NCT07062172 study?
This clinical trial studies the following conditions: Lung Cancer, Driver Mutation.
What interventions are being tested in trial NCT07062172?
The interventions under investigation include: Low Dose CT Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07062172?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07062172 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07062172's enrollment target sits among peer trials
1,753 32nd of 409 higher than 378 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI